Skip to content

Investment Resources

  • Blog

Kyle Dennis FDA Insider Alerts Program | April 29th FDA Insider Watch List

April 29, 2019 by John Gladston

Reminder: Charts are updated every Sunday evening for the next week!

Catalyst Swing Names (1-4 week holds) that I am watching:

 

VtV Therapeutics (VTVT)

Catalyst Dates: Phase 2 Type 1 diabetes data due in June

Buy Zone: $1.25 to $1.50

Profit Zone: $1.90 or higher

Stop Zone: $1.10 or below

 

Pieris Pharmaceuticals (PIRS)

Catalyst Dates: Phase 1 data May 22nd

Buy Zone: $3.00 to $3.20

Profit Zone: $3.75 or higher

Stop Zone: $2.90 or below

Aduro (ADRO)

Catalyst Dates: Phase 1b and Phase 1/2 data due at ASCO June 2 and 3

Buy Zone: $3.75 to $4.00

Profit Zone: $4.90 or higher

Stop Zone: $3.50 or below

 

Sunesis Pharmaceuticals (SNSS)

Catalyst Dates: Phase 1/2 update due between June 13-16

Buy Zone: $1.40 to $1.55

Profit Zone: $1.90 or higher

Stop Zone: $1.25 or below

 

Palatin Technologies (PTN)

Catalyst Dates: FDA Approval Date of June 23rd for Female Sexual Dysfunction

Buy Zone: $1.05 to $1.15

Profit Zone: $1.40 or higher

Stop Zone: $1.00 or below

 

Marinus Pharmaceuticals (MRNS)

Catalyst Dates: Two Phase 2 data sets due in first half (likely June, but no set date)

Buy Zone: $4.20 to $4.50

Profit Zone: $5.20 or higher

Stop Zone: $4.10 or below

 

Sesen Bio (SESN)

Catalyst Dates: Phase 3 data update May 13th

Buy Zone: $.95 to $1.05

Profit Zone: $1.30 or higher

Stop Zone: $.90 or below

 

Sierra Oncology (SRRA)

Catalyst Dates: Phase 1/2 cancer data update likely due out at ASCO in June

Buy Zone: $1.30 to $1.50

Profit Zone: $1.85 or higher

Stop Zone: $1.10 or below

 

Achillion Pharmaceuticals (ACHN)

Catalyst Dates: Phase 2 Interim data May 17th

Buy Zone: $2.75 to $3.00

Profit Zone: $3.50 or higher

Stop Zone: $2.55 or below

 

Ovid Therapeutics (OVID)

Catalyst Dates: Phase 3 data due May 3

Buy Zone: $1.80 to $2.00

Profit Zone: $2.40 or higher

Stop Zone: $1.60 or below

Achieve Life Sciences (ACHV)

Catalyst Dates: Phase 2b data due out mid 2019. Likely May-June

Buy Zone: $3.80 to $4.20

Profit Zone: $5.00 or higher

Stop Zone: $3.25 or below

 

[Ed.note: Kyle Dennis runs BiotechBreakouts.com. He is an event-based trader, who prefers low-priced and small-cap biotech stocks.

To learn more JOIN THIS SPECIAL ONLINE EVENT: 3-Step Plan Kyle Used to Turn $15,253 into $2,855,475 and download his FREE “The $2.9 Million Biotech Trader Playbook here!]

Related

Categories Kyle Dennis Biotech Breakouts Tags $100k Heist Live Event Kyle Dennis, $100k Heist Webinar Kyle Dennis, $100k Heist Webinar Registration Page, $100k Heist Webinar with Kyle Dennis, Biotech Breakouts, biotech breakouts kyle dennis review, biotech breakouts login, Biotech Breakouts Review, Biotech Breakouts reviews, Biotech Breakouts scam, Biotech Breakouts Stock Alerts Service Review, Biotech Breakouts Stock Alerts Service Scam, Biotech Nucleus, Biotech Nucleus Cost, Biotech Nucleus Customer Review, Biotech Nucleus Good, Biotech Nucleus Kyle, Biotech Nucleus Kyle Dennis, Biotech Nucleus Legit, Biotech Nucleus Real Member Review, Biotech Nucleus Review, Biotech Nucleus Reviews, Biotech Nucleus Scam, Biotech Nucleus User experience, Black Optics Review, Black Optics Reviews, Black Optics Scam, Black Optics Trading Program, Black Optics Trading Strategy, Black Optics Trading System, FDA Insider & Lightning Alerts, FDA Insider & Lightning Alerts Kyle Dennis, FDA Insider & Lightning Alerts Review, FDA Insider & Lightning Alerts Reviews, FDA Insider & Lightning Alerts Scam, FDA Insider Alert Free, FDA Insider Alert review, FDA Insider Alert reviews, FDA Insider Alert scam, fda insider alerts, How to turn $5K into $100K, How YOU Could "Steal" $100k From Wall Street, I.G.N.I.T.E., I.G.N.I.T.E. Options Kyle Dennis, I.G.N.I.T.E. Options Strategy, I.G.N.I.T.E. Options Strategy Kyle Dennis, I.G.N.I.T.E. Review, Join The Heist, kyle biotech breakouts, Kyle Dennis, Kyle Dennis Black Optics, Kyle Dennis Black Optics Complaints, Kyle Dennis Black Optics Fraud, Kyle Dennis Black Optics Login, Kyle Dennis Black Optics Performance, Kyle Dennis Black Optics Program, Kyle Dennis Black Optics Refund, Kyle Dennis Black Optics Results, Kyle Dennis Black Optics Review, Kyle Dennis Black Optics Reviews, Kyle Dennis Black Optics Scam, Kyle Dennis Black Optics System, Kyle Dennis Black Optics Website, Kyle Dennis FDA Insider & Lightning Alerts, Kyle Dennis FDA Insider & Lightning Alerts Review, Kyle Dennis FDA Insider & Lightning Alerts Scam, Kyle Dennis FDA Insider Alert review, Kyle Dennis fda insider alerts, Kyle Dennis fda insider alerts review, Kyle Dennis fda insider alerts scam, Kyle Dennis lightning alerts, Kyle Dennis lightning alerts review, Kyle Dennis lightning alerts scam, Kyle Dennis review, Kyle Dennis scam, Kyle Dennis Stocks, Kyle Dennis Stocks review, Kyle Dennis Stocks scam, Lightning Alerts Free, Lightning Alerts Review, Lightning Alerts Reviews, Lightning Alerts Scam, Middle-Class Millionaire Kyle Dennis, Middle-Class Millionaire: From $80K in Debt to $3M in Profits through Catalyst Trading, Option Rocket Kyle Dennis, Option Rocket Review, Option Rocket Reviews, Option Rocket Scam, Options Rocket Kyle Dennis, Options Rocket login, Options Rocket Review, Options Rocket Reviews, Options Rocket Scam, Options Rocket User experience, Options Rocket user review, Options Rocket webinar, Options Rocket website, The Heist, The Heist Kyle Dennis, The Heist Review, The Heist Scam
Kyle Dennis Biotech Breakouts Program | April 28th FDA Insider Watch List
Weekly Money Multiplier Program | 39 Minutes. 100% Profits.

Marc Chaikin Prediction - Top Stocks to Buy in 2024

Marc Chaikin Prediction

Join our list

2023 Wealth Protection Kit

Investment in Gold or Silver

“Get The FREE 2023 Wealth Protection Kit Americans Are Using To Protect Their Retirement Savings” – Sean Hannity

Click Here to Request Your Free Guide

Top 7 Trading Resources

Best Trading Advice

Steady Income Investments

Crypto News

Options Trading Strategies

Top Marijuana Stocks

FREE Trade Alerts

Best Blockchain Stocks to Buy

© 2023 Investment Resources • Built with GeneratePress